{"id":51323,"date":"2022-11-29T06:02:25","date_gmt":"2022-11-29T05:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/"},"modified":"2022-11-29T06:02:25","modified_gmt":"2022-11-29T05:02:25","slug":"sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/","title":{"rendered":"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nSonic Healthcare (ASX: SHL) to invest $17.8m to acquire a 19.99% equity holding in Microba at $0.26 per share and is seeking to acquire options for a further 5% stake \u2013 providing Sonic with a strategic shareholding in Microba.\n<\/li>\n<li>\nMicroba and Sonic have agreed initial terms for a strategic partnership to deliver Microba&#8217;s microbiome testing technology into Australia, Germany, United Kingdom, Switzerland, US, NZ and Belgium.\n<\/li>\n<li>\nSonic Healthcare is one of the world\u2019s largest medical diagnostics companies which globally employs more than 41,000 people and generated revenue of $9.3 billion in FY22.\n<\/li>\n<li>\nThe partnership is expected to increase Microba\u2019s addressable market through distribution of Microba\u2019s testing throughout Sonic\u2019s global network of primary and specialist healthcare professionals.\n<\/li>\n<li>\nMicroba\u2019s Chief Executive Officer, Dr Luke Reid, discusses the strategic partnership announced today in this video: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DtKTlULw90l8&amp;esheet=52984580&amp;newsitemid=20221128005863&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DtKTlULw90l8&amp;index=1&amp;md5=9b9b6c0fdf8e513a933875ecddb22cf3\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.youtube.com\/watch?v=tKTlULw90l8<\/a>\n<\/li>\n<\/ul>\n<p>BRISBANE, Australia&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24MAP&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$MAP<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/microbiome?src=hash\" target=\"_blank\" rel=\"noopener\">#microbiome<\/a>&#8212;<b>Microba Life Sciences Limited <\/b>(ASX: MAP) (\u201c<b>Microba<\/b>\u201d or the \u201c<b>Company<\/b>\u201d) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (\u201c<b>Sonic<\/b>\u201d) has agreed to invest $17.8m to acquire a 19.99% shareholding in Microba. In addition, Sonic is seeking to acquire options for an additional 5% equity position, subject to shareholder approval. Exercise of the options by Sonic would result in a further investment of $7.5m in Microba.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/5\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1408941\/5\/Microba-logo-RGB-colour-TM.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1408941\/21\/Microba-logo-RGB-colour-TM.jpg\"><\/a><\/p>\n<p>\nMicroba and Sonic have also agreed initial binding terms for a strategic alliance to deliver Microba&#8217;s microbiome testing technology into Australia, New Zealand, Germany, United Kingdom, Belgium, Switzerland and the United States.\n<\/p>\n<p>\n<b>Microba\u2019s Chief Executive Officer, Dr Luke Reid<\/b> said, \u201cWe are excited to have Sonic Healthcare, a global leader in healthcare, become a major strategic shareholder and partner. Sonic is globally respected for its leadership in delivering trusted medical diagnostic services, and our partnership deeply aligns the interests of both companies to bring microbiome testing and therapeutics into the hands of clinicians and patients globally to improve standard of care.\n<\/p>\n<p>\n\u201cThis strategic partnership with Sonic is set to accelerate international distribution of Microba\u2019s microbiome testing into primary and specialist healthcare, and move our testing deeper into routine patient management.\u201d\n<\/p>\n<p>\n<b>Sonic Healthcare\u2019s Chief Executive Officer, Dr Colin Goldschmidt<\/b> said, \u201cSonic Healthcare prides itself on delivering accurate, reliable medical diagnostics services using leading laboratory and informatics technologies. Our partnership with Microba exemplifies our commitment to invest in cutting edge developments in laboratory medicine. We see microbiome testing becoming a key part of pathology over coming years and are excited about the potential of this partnership and the opportunities that Microba&#8217;s technology will provide for Sonic\u2019s global operations, our referring clinicians, and our patients.\u201d\n<\/p>\n<p>\n<b>Sonic acquires strategic stake in Microba<\/b>\n<\/p>\n<p>\nSonic has entered into an equity subscription agreement to acquire a 19.99% stake in Microba, through the issue of new fully paid ordinary shares (<b>Shares<\/b>), at an issue price of $0.26 per share and representing a 25% premium to the 5-day VWAP of Microba shares ending on the date prior to this announcement, raising $17.8m in new capital for the Company.\n<\/p>\n<p>\nThe Shares will be issued within Microba&#8217;s existing placement capacity under ASX Listing Rule 7.1 and 7.1A. Following the issue of these Shares, Sonic will be a substantial shareholder, holding a relevant interest in 19.99% of the issued share capital of Microba.\n<\/p>\n<p>\nFurthermore, Sonic seeks to acquire unlisted options exercisable at 33c per share with an expiry of 18 months after the date the Shares are issued. The option exercise price represents a 58% premium to the 5-day VWAP of Microba shares ending on the date prior to this announcement. If exercised, the options would represent a further 5% of the issued share capital in Microba following completion of the share issue and will only be issued subject to receiving shareholder approval for the purpose of ASX Listing Rule 7.1 at a General Meeting, which is expected to be in held in February 2023, the approval of which will be recommended by the Board of Microba. The exercise of the options will be subject to compliance by Sonic with the <i>Corporations Act 2001<\/i> (Cth).\n<\/p>\n<p>\n<b>Strategic relationship<\/b>\n<\/p>\n<p>\nMicroba and Sonic have entered into initial terms of an agreement which enables Sonic Healthcare Limited and its subsidiaries to exclusively distribute Microba\u2019s microbiome testing products to its customers, including general practitioners and specialists, across Germany, Belgium and the United Kingdom for a period of 1 year commencing on 31 January 2023 with the intention to extend subject to finalisation of full license and distribution agreements. The initial agreed terms also provide Sonic Healthcare Limited and its subsidiaries with non-exclusive distribution rights for Switzerland, the United States, Australia and New Zealand.\n<\/p>\n<p>\nAll license and distribution agreements will accommodate existing Microba service delivery and distribution arrangements. The full license and distribution arrangements are expected to be finalised over the coming months.\n<\/p>\n<p>\n<b>Sonic Chief Medical Officer to join Microba\u2019s Medical Advisory Board<\/b>\n<\/p>\n<p>\nWith the two companies\u2019 united strategic objectives to bring cutting-edge microbiome testing into routine healthcare, Sonic Healthcare\u2019s Group Chief Medical Officer, Dr Stephen Fairy, will join Microba\u2019s Medical Advisory Board, responsible for governing the medical and scientific direction of Microba\u2019s commercial activities. Dr Fairy will join a high-profile group of medical professionals on Microba\u2019s Medical Advisory Board comprising Prof. Ian Frazer (AC), Prof. Paul Griffin, Prof. Jake Begun and Dr Chris Hogan (OAM). Sonic will not currently seek a position on Microba\u2019s Board of Directors.\n<\/p>\n<p>\n<strong>About Sonic Healthcare<\/strong>\n<\/p>\n<p>\nSonic Healthcare is one of the world\u2019s leading healthcare providers, with a reputation for excellence in laboratory medicine\/pathology, radiology and primary care medical services, across operations in Australasia, Europe and North America. Employing over 41,000 people globally, Sonic is the largest private pathology operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand and the third-largest in the USA.\n<\/p>\n<p>\n<strong>About Microba Life Sciences Limited<\/strong>\n<\/p>\n<p>\nMicroba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions.\n<\/p>\n<p>\n<strong><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.microba.com%2F&amp;esheet=52984580&amp;newsitemid=20221128005863&amp;lan=en-US&amp;anchor=www.microba.com&amp;index=2&amp;md5=cb554f7daef255db23630312a69a83fa\" rel=\"nofollow noopener\" shape=\"rect\">www.microba.com<\/a><\/strong>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<strong>Simon Hinsley<\/strong><b> <\/b><a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;s&#x69;&#x6d;&#111;n&#64;&#x6e;&#119;&#114;c&#x6f;&#x6d;&#109;u&#x6e;&#x69;&#99;&#97;t&#x69;&#x6f;&#110;s&#x2e;&#x63;&#111;m&#x2e;&#x61;&#117;\" rel=\"nofollow noopener\" shape=\"rect\">&#x73;&#x69;&#x6d;&#x6f;&#x6e;&#x40;&#x6e;&#119;&#114;&#99;&#111;&#109;muni&#x63;&#x61;&#x74;&#x69;&#x6f;&#x6e;&#x73;&#x2e;&#99;&#111;&#109;&#46;&#97;u<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sonic Healthcare (ASX: SHL) to invest $17.8m to acquire a 19.99% equity holding in Microba at $0.26 per share and is seeking to acquire options for a further 5% stake \u2013 providing Sonic with a strategic shareholding in Microba. Microba and Sonic have agreed initial terms for a strategic partnership to deliver Microba&#8217;s microbiome testing &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51323","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Sonic Healthcare (ASX: SHL) to invest $17.8m to acquire a 19.99% equity holding in Microba at $0.26 per share and is seeking to acquire options for a further 5% stake \u2013 providing Sonic with a strategic shareholding in Microba. Microba and Sonic have agreed initial terms for a strategic partnership to deliver Microba&#8217;s microbiome testing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-29T05:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership\",\"datePublished\":\"2022-11-29T05:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/\"},\"wordCount\":1055,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221128005863\\\/en\\\/1649147\\\/21\\\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/\",\"name\":\"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221128005863\\\/en\\\/1649147\\\/21\\\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\",\"datePublished\":\"2022-11-29T05:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221128005863\\\/en\\\/1649147\\\/21\\\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221128005863\\\/en\\\/1649147\\\/21\\\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/","og_locale":"en_US","og_type":"article","og_title":"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership - Pharma Trend","og_description":"Sonic Healthcare (ASX: SHL) to invest $17.8m to acquire a 19.99% equity holding in Microba at $0.26 per share and is seeking to acquire options for a further 5% stake \u2013 providing Sonic with a strategic shareholding in Microba. Microba and Sonic have agreed initial terms for a strategic partnership to deliver Microba&#8217;s microbiome testing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-29T05:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership","datePublished":"2022-11-29T05:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/"},"wordCount":1055,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/","url":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/","name":"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg","datePublished":"2022-11-29T05:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221128005863\/en\/1649147\/21\/Microba-Life-Sciences-Microbiome-Testing-Services.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51323"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51323\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}